Compare Abeona Therapeutics Inc (ABEO) vs iShares MSCI India ETF (INDA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs iShares MSCI India ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while iShares MSCI India ETF trades at $50.06. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, iShares MSCI India ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | INDA | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $7.45 | $55.29 |
52-Week Low | $4.17 | $45.42 |
Enterprise Value | $276.10M | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About iShares MSCI India ETF
INDA tracks the MSCI India Index, providing broad exposure to large and mid-cap companies in the Indian stock market. It is structurally dominated by the financials, information technology, and energy sectors, serving as a core instrument for investors seeking a single-country view of India's long-term economic growth.
Read more on INDA →
